Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2.
Intern Med J
; 52(12): 2172-2175, 2022 12.
Article
in En
| MEDLINE
| ID: mdl-36436197
ABSTRACT
Coronavirus disease 2019 (COVID-19) infection in patients with haematological neoplasms has been associated with increased mortality; however, many studies in this patient group were reported early in the pandemic. The authors evaluated outcomes of COVID-19 infection in patients with haematological conditions following widespread vaccination, newer viral variants and increasingly effective antiviral therapies. A 4% mortality rate was found and contemporary risk factors for hospitalisation including older age, nonvaccination or partial COVID-19 vaccination status and infection with non-Omicron strain were identified.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematologic Neoplasms
/
COVID-19
/
Hematology
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Intern Med J
Journal subject:
MEDICINA INTERNA
Year:
2022
Document type:
Article
Affiliation country:
Australia
Publication country:
AU
/
AUSTRALIA
/
AUSTRÁLIA